Lipitor MDL News: Zoll, Kranz & Borgess Notes The Lipitor MDL Is...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor.(PRWeb February 20, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11601175.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 20, 2014 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuits Involving Type 2 Diabetes Consolidated in South...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly suffer from Type 2 diabetes due to their use of Lipitor.(PRWeb February 19, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11598721.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 20, 2014 Category: Pharmaceuticals Source Type: news
China Atorvastatin & Trastuzumab Market with 2018 Forecasts in New...
ChinaMarketResearchReports.com adds Latest Reports on Atorvastatin and Trastuzumab industry for China to its store.(PRWeb February 15, 2014)Read the full story at http://www.prweb.com/releases/atorvastatin-trastuzumab/china-market-reports/prweb11585316.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 16, 2014 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuit News: Bernstein Liebhard Notes Recent Action Taken by...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor.(PRWeb February 13, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11583053.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2014 Category: Pharmaceuticals Source Type: news
NICE publishes new draft guidelines on statins use
"Millions more people should be put on cholesterol-lowering statin drugs," BBC News reports. Draft guidance from the National Institute for Health and Care Excellence (NICE) has recommended that the drugs should be given to people with an estimated 1 in 10 or more risk of cardiovascular disease (CVD), which includes conditions such as heart disease and stroke.
Statins are medicines that can help lower rates of low-density lipoprotein (LDL) cholesterol (so-called "bad" cholesterol) in the blood. High rates of LDL cholesterol can lead to hardening of the arteries, a risk factor for CVDs.
At present,...
Source: NHS News Feed - February 12, 2014 Category: Consumer Health News Tags: Heart/lungs Medication QA articles Source Type: news
Lipitor Lawsuit Hearing Rescheduled for February after Winter Weather...
The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin.(PRWeb February 02, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11544689.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 3, 2014 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuits Move Forward, with Federal Judicial Panel Set to...
The Firm is investigating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the statin medication.(PRWeb January 28, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11530077.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 29, 2014 Category: Pharmaceuticals Source Type: news
New guidelines for taking cholesterol-lowering drugs target cardiovascular risk, not cholesterol level
For years, doctors prescribed the cholesterol-lowering drugs known as statins based largely on cholesterol test results. But new guidelines from the American Heart Association and the American College of Cardiology propose a major change to that strategy, reports the February 2014 Harvard Heart Letter.
"The new guidelines shift away from a target-driven approach to a risk-driven approach," says Dr. Reena Pande, a cardiologist at Harvard-affiliated Brigham and Women's Hospital and an instructor in medicine at Harvard Medical School. Instead of striving to reach a specific cholesterol value, doctors should consider a person'...
Source: New Harvard Health Information - January 27, 2014 Category: Consumer Health News Source Type: news
All Lots of Liptruzet in U.S. Recalled Over Packaging Defect (FREE)
By Larry Husten
All lots of the combination cholesterol-lowering drug Liptruzet (ezetimibe and atorvastatin) in the U.S. are being recalled because a packaging defect could … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 15, 2014 Category: Primary Care Source Type: news
Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit...
The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to Lipitor.(PRWeb January 14, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11488510.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 15, 2014 Category: Pharmaceuticals Source Type: news
Large-scale Cholesterol Drug Recall Announced for LiptruzetLarge-scale Cholesterol Drug Recall Announced for Liptruzet
Merck says it is recalling all lots of the ezetimibe/atorvastatin combination drug in four different doses due to a packaging defect. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 14, 2014 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Packaging Defect Leads Merck To Recall All Lots of Liptruzet In US
Merck said today that it was recalling all lots of Liptruzet, its combination of the cholesterol-lowering drugs ezetimibe and atorvastatin, in the US. The company said the recall was due to a packaging defect which could potentially allow air and moisture to affect the quality of the drug, though the company said "the likelihood of the packaging defects decreasing the effectiveness of Liptruzet on a patient’s lipid profile or negatively impacting the safety of the product is remote." To date there have been no adverse events or product complaints reported to the company. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 14, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of...
The Firm is investigating potential Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the cholesterol lowering statin.(PRWeb January 08, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11472635.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 11, 2014 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuit News: Federal Judicial Panel to Reconsider...
The Firm is investigating Lipitor lawsuits on behalf of individuals who were treated with the cholesterol-lowering statin, and who went on to develop new-onset Type 2 diabetes.(PRWeb December 24, 2013)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11447682.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 26, 2013 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New...
The Firm is investigating Lipitor lawsuits on behalf of patients who used the cholesterol lowering statin, and who went on to develop new-onset Type 2 diabetes.(PRWeb December 16, 2013)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11427875.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 17, 2013 Category: Pharmaceuticals Source Type: news
